News
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 January 2026
Dexa Group’s Consistent Reputation Management Wins the 8th Indonesia Public Relations Awards
Winning the award for eight consecutive times, Dexa Group demonstrates long-term consistency in building public trust. This commitment has once again led Dexa Group to receive the Indonesia Public Relations Awards (IPRA) 2026 with the title of Best Public Relations 2026 in Public Trust Building through Ethical Pharmaceutical Practices. This…
1 November 2023
Dexa Group Partners Up with BPOM to Reach Net Zero Emission
Dexa Group participates in supporting collaboration between the Indonesian Food and Drug Authority (BPOM) and business actors for the Net Zero Carbon Program through planting mangroves in the Angke Nature Tourism Park (TWAA) Kapuk area, Jakarta, on Tuesday, 31 October 2023. This program implements the Sustainable Development Goals (SDG) and…
28 October 2023
Stunting Rate Reaches 34,9%, Dexa Medica Collaborates with BKKBN in Educating Hundreds of Midwives in Jember
In the 2024 State Budget and Revenue (APBN), President Joko Widodo allocated IDR 186.4 trillion or 5.6 percent for the health sector. One of the primary goals is to reduce the prevalence of stunting in Indonesia to 14 percent by 2024. To accelerate the stunting reduction target of 14 percent…
28 October 2023
Prof. Raymond Tjandrawinata, a Pioneer of Indonesian Indigenous Modern Medicine Provides Education in Stunting Prevention
The 2022 Indonesian Nutrition Status Survey (SSGI) reported that the prevalence of stunting in Jember reached 34.9%, the highest in East Java. Pharmacologist Prof. Raymond R. Tjandrawinata provided education at the Education on Stunting Intervention for Midwives program in Jember Regency to accelerate the stunting reduction to 14% by 2024…
23 October 2023
Dexa Group Continues Participating in the Global Market by Attending the 38th Trade Expo Indonesia
Dexa Group participated at the 38th Trade Expo Indonesia as a sign of commitment and continuity in the export industry. Dexa Group took part by setting up a booth with top export products such as Indonesia Indigenous Modern Medicine (OMAI), Boska, and Glucient SR. Mrs. Gracianti Soetikno, Commissioner of Dexa Group,…
10 September 2023
Dexa Medica and the Indonesian National Army (TNI AD) Collaborate to Reduce Stunting
Dexa Medica continues collaborating with diverse stakeholders to play an active role in the program to reduce stunting to 14% by 2024. Dexa Medica collaborated with the Indonesian National Army (TNI AD) and the Family Coordinating Agency National Planning (BKKBN) on this occasion to launch the e-Stuntad and e-Posyandu apps…
5 September 2023
Dexa Medica Halal Product Guarantee System Wins Halal Award
Dexa Group once again received the Halal Award from the Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia (LPPOM MUI) in the Best Social Contribution on Halal environment category, demonstrating its dedication to establishing a halal environment in Indonesia. "I congratulate all companies and business actors nominated for and…
28 August 2023
Dexa Medica Contributes to PIT IAI, Support Advancement, and Faces Pharmaceutical Challenges
Dexa Medica participated in the Annual Scientific Meeting (PIT) of the Ikatan Apoteker Indonesia (IAI) in Solo City, Central Java, on August 24 -26, 2023, as a form of collaboration in supporting advancement and facing challenges in the pharmaceutical and health fields in accordance with the Dexa Medica's core purpose,…